| #81 |
Ramajeyam Gopalraj |
IBM |
1 |
| #81 |
Somnath A. Gulye |
Emc |
1 |
| #81 |
Komal G. Khungar |
Tekelec |
1 |
| #81 |
Jennifer G. Rasimas |
Nortel Networks Limited |
1 |
| #81 |
Eleftherios Kougoulos |
Novan |
1 |
| #81 |
Ramon M. Spence |
IBM |
1 |
| #81 |
Barnaby L. Court |
IBM |
1 |
| #81 |
Robert Neil Hunter, III |
Smithkline Beecham Limited |
1 |
| #81 |
Haiping Hong |
Bioriginal Food & Science |
1 |
| #81 |
Yi Yang |
Cisco |
1 |
| #81 |
Cheryl M. Defontes |
Syngenta Participations Ag |
1 |
| #81 |
Philippe Ragot |
Glaxo Group Limited |
1 |
| #81 |
Jeffrey Schons |
Glaxo Group Limited |
1 |
| #81 |
James C. Riordan |
IBM |
1 |
| #81 |
Srinivas Cheemalapati |
IBM |
1 |
| #81 |
Malcolm D. James, Sr. |
Cree |
1 |
| #81 |
Andrew James Carpenter |
Glaxosmithkline |
1 |
| #81 |
Paal Selnaes |
— |
1 |
| #81 |
Christopher Joseph Aquino |
Smithkline Beecham Limited |
1 |
| #81 |
Brian Dale |
Genx International |
1 |
| #81 |
Narinder Makin |
IBM |
1 |
| #81 |
Brent H. Daniel |
IBM |
1 |
| #81 |
Latha Sivakumar |
IBM |
1 |
| #81 |
Jai Singh Arun |
IBM |
1 |
| #81 |
Christina Lynn Vucich |
— |
1 |
| #81 |
Paul Altendorf |
Syngenta Participations Ag |
1 |
| #81 |
Deepan Natesan Seeralan |
— |
1 |
| #81 |
Gavin Richard Cato |
Dell Products |
1 |
| #81 |
Marit L. Imsdahl |
IBM |
1 |
| #81 |
Nicholas R. Pace |
Cisco |
1 |
| #81 |
Jared Conville |
Syngenta Participations Ag |
1 |
| #81 |
Matthew J. Sheard |
IBM |
1 |
| #81 |
Jeffrey E. Skinner |
Lenovo (Singapore) Pte. |
1 |
| #81 |
Mark Steven Critzer |
Dupont Electronics |
1 |
| #81 |
Cameron Bowe |
— |
1 |
| #81 |
Ginger Rothrock |
University Of North Carolina At Chapel Hill |
1 |
| #81 |
Jacob Yackenovich |
IBM |
1 |
| #81 |
Derrick L. Washington |
IBM |
1 |
| #81 |
Yaping Shou |
Glaxo Group Limited |
1 |
| #81 |
Ayush VERMA |
Glaxosmithkline Biologicals Sa |
1 |
| #81 |
Jun Tang |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #81 |
Hope Hart |
Syngenta Participations Ag |
1 |
| #81 |
Frederick S. Walters |
Monsanto Technology |
1 |
| #81 |
Richard Adams |
Glaxo Group Limited |
1 |
| #81 |
Jeffrey S. Holland |
— |
1 |
| #81 |
Walter A. Goodman |
IBM |
1 |
| #81 |
Steven Thomas Dock |
Intarcia Therapeutics |
1 |
| #81 |
Patrick John O'Flaherty |
Cree |
1 |
| #81 |
Paulo Cezar De Lucca |
Queensland University Of Technology |
1 |
| #81 |
Gregory W. Warren |
Novartis Finance |
1 |